German pharmaceutical spending up by 5%
This article was originally published in Scrip
German spending on pharmaceuticals in 2007 rose by 5% to reach €41.7 billion, according to federal statistics office (Destatis) data released to coincide with World Health Day 2009.
You may also be interested in...
The UK has added important new capabilities to its COVID-19 monitoring and control effort and those running it promise a “world class system” by late summer.
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
The advent of COVID-19 and its effects on care delivery have meant that short-term priorities for health care systems have switched temporarily to public health emergency mode. But the longer-term need to restructure delivery around outcomes and federated data management for patients is here to stay, says Royal Philips’ Jeroen Tas.